Terminated: Minrad International Ends Agreement with RxElite

Minrad International has terminated its distribution agreement with RxElite. The action was taken after the RxElite failed to pay $5.6 million in accounts owed to Minrad. Prior to September 2008, RxElite had held the exclusive distribution rights for Minrad produced anesthetic gases in the U.S. human market....

Mike Landess’ Battle with Prostate Cancer

A quick shout to Mike Landess, a Denver, CO newsman who this week released a half hour DVD special on prostate cancer (check out his blog). Mike was diagnosed with the disease in November 2006. The DVD, Prostate Cancer: My Story, chronicles every step of Mike’s journey from diagnosis, to doctors’...

[Video Profile] Interview with Michael Fons, VP Corporate Development at Inovio Biomedical

Inovio Biomedical’s electroporation technology uses brief, controlled electrical pulses to increase cellular uptake of gene expression in DNA-based treatments; this enhances the potency of DNA-based immunotherapies against cancers and infectious diseases. Inovio has an extensive patent portfolio and line...

AngioDynamics: Irreversible Electroporation Shows Early Promise

AngioDynamics announced the first percutaneous use of NanoKnife, an irreversible electroporation (IRE) device. Although its too early to estimate the product’s prospects, under AngioDynamics watch, IRE has blockbuster potential. Synergies with the company’s other oncology products (which use radio...

Trod Medical: FDA 510(k) Clearance for Encage

Trod Medical has received FDA 510(k) clearance for Encage, a minimally invasive technology for soft tissue ablation. The surgical system allows for precise percutaneous ablation of target tissue with well-defined margins, helping spare healthy surrounding tissue. Encage electrodes are inserted percutaneously...

Liquidity Crisis: Minrad International Slashes Jobs, Evaluates Options

In an effort to improve its cost structure and conserve cash, Minrad International said it would layoff 35 percent of its workforce, or some 50 jobs. The layoffs come after a dismal third quarter. Despite revenue growth, the company’s net loss widened to $10.8 million, double last year’s third quarter...

SyntheMed: FDA Clearance for SinusShield

SyntheMed, of Iselin, NJ, has received FDA 510(k) clearance for SinusShield, a bioresorbable membrane to prevent post-operative adhesions from forming after nasal and sinus surgeries. It’s common for surgeons to place silastic tubes or sheets in the sinus passages to prevent blockage caused by scar tissue....

Candela Buys Some Time

Shares of Candela Corporation, a maker of aesthetic lasers, jumped 31% yesterday after the U.S. District Court agreed to postpone the patent litigation suit brought by Palomar Medical in August 2006. Candela filed a motion requesting a stay on October 31st after the company learned that that a reexamination...